Thursday, August 29, 2013 4:25:16 PM
Cubist announces recall of antibiotic; shares rise regardless
Don Seiffert
Associate Editor MHT-
Boston Business Journal
Cubist Pharmaceuticals Inc. (Nasdaq: CBST) announced a voluntary recall of certain batches of its antibiotic, Cubicin, due to the possibility that they contain particles of glass.
The Lexington, Mass. drug company specified four lots of the drug in an announcement Thursday, all of them for the 500 milligram strength of the injected drug. The lots are: 950453F, with a Dec. 6, 2013 expiration date; 090203F, with a Sept. 7, 2014 expiration date; 201703F, with expiration date of Aug. 31, 2015; and 201653F, with expiration date of Sept. 1, 2015.
Cubicin said there have been no “adverse events” reported.
The company’s stock was up Thursday 2 percent despite the recall, as investor interest in antibiotic companies soars due to international warnings regarding antibacterial resistance, and two pending acquisitions for which Cubist plans to pay as much as $1.62 billion if certain milestones are met. Cubicin’s stock is up 42 percent for the year to date.
=============================================================
Yet and still TSRX PPS stays stagnant,for the most part.
Take Care and God Bless....God Bless Us All.
Truth4Once
I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of solutions.
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM